AzTrials
AzTrials

Lumbosacral Disc SyndromeNCT07068321

Effects Of GDS Method Along With CBTThrough Smartphone Health App For Patients With Chronic LDP

A study testing Godelieve Denis-Struf and Godelieve Denis-Struf + Cognitive Behavioral Therapy in people with Lumbosacral Disc Syndrome, run by Superior University at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Chronic lumbosacral discogenic pain is a common and debilitating condition that significantly affects the quality of life of patients. Traditional treatments often focus on pain management, but a holistic approach combining physical exercises and psychological therapy can offer more sustainable relief. Read more about this study

Who is it for?
Ages 40 to 65 years
Conditions the study is for
Lumbosacral Disc Syndrome
What is being tested?
Godelieve Denis-Struf and Godelieve Denis-Struf + Cognitive Behavioral Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
159 participants
Where
1 sitePakistan
Study dates
17 Apr 2025to 1 Jun 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age of 40 to 65 years
  • Diagnosed chronic lumbosacral discogenic pain by a physician or neuro-physician.
  • No surgical history of lumbosacral area

Who cannot join

  • Pregnancy
  • Diagnosis of cancer
  • Fibromyalgia or inflammatory disease (eg, rheumatoid arthritis or spondylitis)
  • Surgical cases of lumbosacral area
  • comorbidity like uncontrolled diabetes and blood pressure

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Rehabilitation Centers in Punjab

    Lahore, Punjab Province

Other trials in Pakistan

About this study

Official title: Effects Of Godelieve Denis-Struf (GDS) Method Along With Cognitive Behavioral Therapy Through Smartphone Health App For Patients With Chronic Lumbosacral Discogenic Pain.

Chronic lumbosacral discogenic pain is a common and debilitating condition that significantly affects the quality of life of patients. Traditional treatments often focus on pain management, but a holistic approach combining physical exercises and psychological therapy can offer more sustainable relief.

Read the detailed description

The Godelieve Denis-Struf (GDS) method has been shown to improve posture, mobility, and muscular imbalances in patients with musculoskeletal pain. Cognitive Behavioral Therapy (CBT) is another effective intervention that addresses the psychological factors contributing to chronic pain. With the rise of digital health solutions, smartphone applications have emerged as convenient tools to deliver these therapeutic methods. This study explores the combined effects of GDS exercises and CBT via a smartphone health app for individuals suffering from chronic lumbosacral discogenic pain.

Being tested
Control Group (transcutaneous electrical nerve stimulation), Godelieve Denis-Struf, Godelieve Denis-Struf + Cognitive Behavioral Therapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Control Group (transcutaneous electrical nerve stimulation)Combination product

    Control Group will consist of 20 sessions of 30 min, applied twice per week over a period of 3 months including transcutaneous electrical nerve stimulation, and standardized exercises for LBP through smart phone application.

  • Godelieve Denis-StrufCombination product

    Experimental Group will receive 20 sessions of 30 min applied twice per week over a period of 3 months of GDS treatment through smart phone application.

  • Godelieve Denis-Struf + Cognitive Behavioral TherapyCombination product

    Experimental Group 2 will receive 20 sessions of 45 min applied twice per week over a period of 3 months of GDS along CBT treatment through smart phone application.

Study groups in NCT07068321
Study groupRoleWhat they receive
Control Group (transcutaneous electrical nerve stimulation)ExperimentalNot described
Receives: Combination Product: Control Group (transcutaneous electrical nerve stimulation)
Godelieve Denis-StrufActive comparatorNot described
Receives: Combination Product: Godelieve Denis-Struf
Godelieve Denis-Struf + Cognitive Behavioral TherapyActive comparatorNot described
Receives: Combination Product: Godelieve Denis-Struf + Cognitive Behavioral Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Oswestry Disability Index (ODI)

    The Oswestry Disability Index (ODI) is a questionnaire used to assess the impact of low back pain on a person's daily life. It consists of 10 sections, each with six statements, and patients select the statement that best describes their situation. Each section is scored from 0 to 5, with 0 indicating no disability and 5 indicating the worst imaginable disability. The total score is then calculated and can be expressed as a percentage, with a higher score indicating greater disability

    Measured: 18 Months

  2. SF-36 (Short Form 36)

    The SF-36 (Short Form 36) is a questionnaire used to assess health-related quality of life, encompassing both physical and mental well-being. It consists of 36 items that evaluate eight health domains: physical functioning, role limitations due to physical health, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Scores for each domain range from 0 to 100, with higher scores indicating better health

    Measured: 18 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jul 2025
  2. Study start17 Apr 2025
  3. Primary completion1 Dec 2025 (estimated)
  4. Study completion1 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
159 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07068321
Sponsor's protocol ID
PhDRSW/Batch-Fall23/2221
Status last verified
Jul 2025
First submitted
7 Jul 2025
Last updated
16 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Godelieve Denis-Struf and Godelieve Denis-Struf + Cognitive Behavioral Therapy in people with Lumbosacral Disc Syndrome, run by Superior University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 16 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Oswestry Disability Index (ODI) (time frame: 18 Months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in